TP53 and cancer: Additionally, the present study failed to use the method of co-staining macrophages (CD11b) with the relevant molecules (such as MHC-II or p53) in the histological detection of tumor grafts, which has limitations in determining whether the positively expressed proteins in the cancer tissues originated from macrophages or tumor cells.